Silencing of lincRNA-ROR inhibits BC cell proliferation, increases sensitivity to tamoxifen, and represses the activation of the PI3K/Akt/mTOR signaling pathway in MDA-MB-231 cell [203]. Here, LINC-ROR is linked to breast cancer.